Filing Details
- Accession Number:
- 0001209191-20-036289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-12 16:32:31
- Reporting Period:
- 2020-06-10
- Accepted Time:
- 2020-06-12 16:32:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1446847 | Ironwood Pharmaceuticals Inc | IRWD | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1224341 | S Lawrence Olanoff | C/O Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston MA 02110 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2020-06-10 | 11,350 | $10.06 | 68,629 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $10.78,inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in thisfootnote.